Intelligence / Healthtech / New Clinical Trials
ClinicalLIVEUpdated 18 Nov 2026
New Clinical Trials
Clinical trials companies registered in the last 30 days, worldwide, with the sponsor, phase and countries.
Sources: ClinicalTrials.gov · Rebuilt weekly · Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase.
Trials
777
in the 30 days to 2026-11-18
Added in 30 days
777
to 18 Nov 2026
Top country
United States
192 · 25% of the list
Phase covered
8
distinct values
Snapshot · 18 Nov 2026
Explore all 777 Growth
By month
777
Signals
What the register says this week, and why it matters if you sell into it.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
- 174 of the listed studies are device, diagnostic or digital-health studies (no drug phase).
- A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
PostedSponsorStudyPhaseStatus
17 Nov 2026Beijing Xunsheng Biomedical Research Co., Ltd.ChinaAVL-102 for the Treatment of HPV 16/18/52/58-Related High-Grade LesionsPhase 1Recruiting17 Nov 2026Boryung Biopharma Co., Ltd.South KoreaA Study to Evaluate the Efficacy and Safety of BRC-201 in Patients With Acute Uncomplicated InfluenzaPhase 3Recruiting17 Nov 2026Bristol-Myers SquibbA Study to Evaluate the Safety and Efficacy of Mavacamten in Adults With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy (SOLSTICE-HCM)Phase 3Not Yet Recruiting17 Nov 2026CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.ChinaA Study of SYH2053 Injection in Participants With Hepatic Impairment Compared to Participants With Normal Hepatic FunctionPhase 1Recruiting17 Nov 2026Dorian Technologies S.r.l.ItalyCorrelation Between Visual Reading and DOlab Software Quantitative Analysis of DaT-SPECT ImagesRecruiting17 Nov 2026Eli Lilly and CompanyUnited StatesA Study of LY3945262 in Healthy ParticipantsPhase 1Not Yet Recruiting17 Nov 2026GenAns Biotechnology Co., LtdChinaGA001 Injection in Retinitis PigmentosaPhase 2Not Yet Recruiting17 Nov 2026GRIN Therapeutics, Inc.A Phase 1b Study of Radiprodil in Participants With GRIN-Related Neurodevelopmental Disorder Caused by Non-Gain-of-Function VariantsPhase 1Not Yet Recruiting17 Nov 2026Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.ChinaA Study of HW201877 Capsules for Participants With Moderate to Severe Active Inflammatory Bowel Disease (IBD)Phase 2Not Yet Recruiting17 Nov 2026Innatus Therapeutics (Shanghai) Co., Ltd.ChinaA Phase I Study of INT-1868 Tablets in Healthy Adult Participants (INT-1868-I101)Phase 1Not Yet Recruiting17 Nov 2026Janssen Research & Development, LLCA Study of JNJ-99220732 in Participants With Advanced or Metastatic Solid TumorsPhase 1Not Yet Recruiting17 Nov 2026Kinetic Performance S.L.SpainEffects of Zynamite S on Fatigue, Mood, Sleep, Safety, and Tolerability in Healthy AdultsNot applicableCompleted17 Nov 2026MSK Doctors & Associates LtdEffect of Non-Compressive Semiconductor Embedded Therapeutic Gloves on Osteoarthritis of the HandNot applicableNot Yet Recruiting17 Nov 2026Nakhia Impex LLCChina35-kDa Hyaluronan Fragment (HA35) Chewable Tablets for Gingival Inflammation, Oral Pain and Pharyngeal DiscomfortNot applicableNot Yet Recruiting17 Nov 2026Nakhia Impex LLCChina10% 35-kDa Hyaluronan Fragment (HA35) Gel for Periocular Comfort and AestheticsNot applicableNot Yet Recruiting17 Nov 2026Novartis PharmaceuticalsA Safety and Tolerability Study of HJB647 in Adult Participants With Uncontrolled HypertensionPhase 1Not Yet Recruiting17 Nov 2026Novo Nordisk A/SUnited StatesA Research Study of a New Medicine NNC0662-3168 for Weight Management and Type 2 DiabetesPhase 1, Phase 2Not Yet Recruiting17 Nov 2026Novo Nordisk A/SUnited StatesA Research Study Investigating How a New Medicine NNC0721-5186 Works in Women Living With Overweight or ObesityPhase 1Not Yet Recruiting17 Nov 2026NS Pharma, Inc.United States, Australia, CanadaA Global Phase 2 Extension Study of Brogidirsen in Boys With Duchenne Muscular DystrophyPhase 2Enrolling By Invitation17 Nov 2026nucleusRx IncUnited StatesDevelopment of a Virtual Health Care Platform in Heart Failure Patients Transitioning From Hospital to HomeNot applicableEnrolling By Invitation17 Nov 2026PathnosticsStandard Culture Versus Advanced Guidance UTI® Testing in Older AdultsNot Yet Recruiting17 Nov 2026PT Equilab InternationalIndonesiaNutritional Status Evaluation in Underweight Indonesian Children Receiving 0.89 kcal/mL Milk Powder - Site ManadoNot applicableRecruiting17 Nov 2026PT Equilab InternationalIndonesiaNutritional Status Evaluation in Underweight Indonesian Children Receiving 0.89 kcal/mL Milk Powder - Site MakassarNot applicableRecruiting17 Nov 2026Reinovax Biologics Co., LTDChinaA Phase Ⅲ Clinical Trial of an Investigative 24-valent Pneumococcal Polysaccharide Conjugate VaccinePhase 3Not Yet Recruiting17 Nov 2026Reistone Biopharma Company LimitedChinaA Study of RSS0343 Tablets in Healthy Participants and in Participants With Mild or Moderate Renal ImpairmentPhase 1Not Yet Recruiting17 Nov 2026Research IncColombiaEnzymatic Treatment for Postoperative Nasal Fibrosis After RhinoplastyNot applicableRecruiting17 Nov 2026SanofiStudy of Hexaxim Compared With Pentaxim Administered With a Monovalent Hepatitis B Vaccine in Healthy Chinese Infants.Phase 3Not Yet Recruiting17 Nov 2026SensorionFranceA Clinical Trial With SENS-601, Injected With SPHYNX Administration System, in the Pediatric Population Presenting With Hearing Loss Related to Pathogenic Variation(s) of GJB2 GenePhase 1, Phase 2Recruiting17 Nov 2026Sensydia CorporationACOUSTIC-1: Acoustic Sensing of Cardiopulmonary HemodynamicsNot Yet Recruiting17 Nov 2026Shanghai Hantong Medical Technology Co., LTDCombined Ultrasound Hepatic and Renal Denervation for Essential HypertensionNot applicableNot Yet Recruiting17 Nov 2026Sinfatin S.LSpainStudy of the Effects of Rimonabant on Functional Recovery in Subacute Stroke PatientsPhase 2Not Yet Recruiting17 Nov 2026SystImmune Inc.United StatesA Multicenter, Open-label, Phase 1/1b, Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of SI-B037 in Solid TumorsPhase 1Recruiting17 Nov 2026Tasly Biopharmaceuticals Co., Ltd.ChinaIntravenous Recombinant Human Prourokinase (rhPro-UK) for Acute Ischemic Stroke Within 4.5 to 24 Hours of OnsetPhase 3Not Yet Recruiting16 Nov 2026Aether Tech S.L.SpainAutomated Oxygen Titration With the EMILY.AI Device During the Six-Minute Walk TestNot applicableRecruiting16 Nov 2026AkesoChinaA Study of AK158D1 in Advanced Solid TumorsPhase 1Not Yet Recruiting16 Nov 2026ANI PharmaceuticalsUnited StatesACUTE-GO is a Study Testing the Effectiveness and Safety of Two Doses of Purified Cortrophin Gel in Patients With Acute Gouty Arthritis FlaresPhase 4Recruiting16 Nov 2026Beijing Jiake Ruikang Pharmaceutical Technology Co., Ltd.ChinaSafety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of JAR-2203 in Healthy Participants With Elevated Plasma Lipoprotein(a)Phase 1Recruiting16 Nov 2026Beijing Konruns Pharmaceutical Co., Ltd.KC1086 in Combination With Fulvestrant for HR-Positive, HER2-Negative Advanced Breast CancerPhase 2Not Yet Recruiting16 Nov 2026BiogenA Study to Learn About the Effects of Felzartamab on Daily Living Activities and Its Safety in Adults With Generalized Myasthenia Gravis (gMG) Ages 18 to 80 Years OldPhase 2Not Yet Recruiting16 Nov 2026Biosensors Europe SAUnited KingdomStudy of the BioRISE Biolimus Drug-Coated Balloon Versus the SELUTION SLR Sirolimus-Coated Balloon in De Novo Coronary Lesions, With a Single-Arm In-Stent Restenosis Cohort (SUNRISE)Early Phase 1Not Yet Recruiting16 Nov 2026Boehringer IngelheimGermanyA Study to Compare How Survodutide is Taken up by the Body When Given in 2 Formulations to People With Overweight or ObesityPhase 1Not Yet Recruiting16 Nov 2026Bristol-Myers SquibbUnited States, CanadaA Study of BMS-986548 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid MalignanciesPhase 1, Phase 2Not Yet Recruiting16 Nov 2026Chendu DIAO Pharmaceutical Group CO., LTD.ChinaPharmacokinetics, Safety, and Tolerability of DA-302168S Tablets in Participants With Varying Degrees of Renal Impairment and Normal Renal FunctionPhase 1Recruiting16 Nov 2026Chengdu Suncadia Medicine Co., Ltd.ChinaA Study of HRS-8046 in Patients With Advanced Solid Tumors: Safety, Tolerability, and PharmacokineticsPhase 1Not Yet Recruiting16 Nov 2026Chengdu Suncadia Medicine Co., Ltd.ChinaA Clinical Trial on the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-9308 Tablet as Monotherapy or Combination Therapy in Participants With Advanced Solid TumorsPhase 1, Phase 2Not Yet Recruiting16 Nov 2026ChinaNormChinaDevice Impact on the Efficacy of Serum Product StudyNot applicableRecruiting16 Nov 2026CooperVision International Limited (CVIL)MexicoTitle: Clinical Performance and Outcomes After Sphere Lens TransitionNot applicableNot Yet Recruiting16 Nov 2026CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.ChinaA Study of SYH2053 Injection in Participants With Renal Impairment Compared to Participants With Normal Renal FunctionPhase 1Recruiting16 Nov 2026CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.ChinaSYH2062 Injection in Participants With Mild to Moderate Essential Hypertension .Phase 2Recruiting16 Nov 2026CStone PharmaceuticalsAustralia, ChinaA First-in-human (FIH), Open-label, and Multi-center Study of CS5006 in Participants With Advanced Solid TumorsPhase 1, Phase 2Not Yet Recruiting// How AOS uses this